The composition and structure of the extracellular matrix plays a central role in the patterning of the cardiovascular system. In addition to its developmental role, the extracellular matrix often initiates thrombus formation. Project 2 is focused on the fundamental mechanisms controlling the assembly of one component of the extracellular matrix, insoluble fibronectin fibrils. The studies will address intracellular mechanisms that control integrin functions essential for the matrix assembly process. In particular, this project will analyze the mechanisms response for """"""""activation"""""""" of the high affinity form of integrin alpha5beta1 and for its physical linkage to the cytoskeleton.
These aims will be accomplished by isolating cell lines with defects in cellular pathways required for activation of integrin alpha5beta1. Expression cDNA cloning will then identify Genes that complement those defects. An alternative strategy will employ enrichment of complemented radiation hybrids to identify chromosomal positions of complementing genes. The genes will then be further localized through use of sequence tagged sites, rescue by transfection with P1 clones and finally rescue by transfection of candidate cDNAs. Analysis of integrin-cytoskeleton linkage will employ novel recombinant structural mimics of the beta cytoplasmic domains and analyze their interactions with two actin binding proteins, filamin and talin. Interactive sites in the integrin and the cytoskeletal proteins will be mapped. This information will be used to test the hypothesis that the differential binding of these proteins to different integrins leads to integrin-specific functions. The studies will provide fundamental insight into the assembly of a critical component of the extracellular matrix of vascular cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL031950-16
Application #
6302191
Study Section
Project Start
2000-02-15
Project End
2000-12-31
Budget Start
Budget End
Support Year
16
Fiscal Year
2000
Total Cost
$321,374
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Klann, Jane E; Kim, Stephanie H; Remedios, Kelly A et al. (2018) Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance. J Immunol 200:4012-4023
Griffin, John H; Zlokovic, Berislav V; Mosnier, Laurent O (2018) Activated protein C, protease activated receptor 1, and neuroprotection. Blood 132:159-169
Sinha, Ranjeet K; Wang, Yaoming; Zhao, Zhen et al. (2018) PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. Blood 131:1163-1171
Xu, Xiaohong Ruby; Wang, Yiming; Adili, Reheman et al. (2018) Apolipoprotein A-IV binds ?IIb?3 integrin and inhibits thrombosis. Nat Commun 9:3608
Gupta, Naveen; Liu, Roland; Shin, Stephanie et al. (2018) SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity. J Antimicrob Chemother 73:1586-1594
Gupta, Naveen; Sinha, Ranjeet; Krasnodembskaya, Anna et al. (2018) The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. Stem Cells 36:796-806
Amar, Arun Paul; Sagare, Abhay P; Zhao, Zhen et al. (2018) Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology 134:293-301
Kamikubo, Yuichi; Mendolicchio, G Loredana; Zampolli, Antonella et al. (2017) Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. Blood 130:1661-1670
Rothmeier, Andrea S; Marchese, Patrizia; Langer, Florian et al. (2017) Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking. Arterioscler Thromb Vasc Biol 37:1323-1331
Subramaniam, Saravanan; Jurk, Kerstin; Hobohm, Lukas et al. (2017) Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129:2291-2302

Showing the most recent 10 out of 428 publications